Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Barlogie · SciRah

Researcher profile · Semantic Scholar

B. Barlogie

Share profile

B. Barlogie — researcher profile on SciRah

h-index: 142
Works: 1,122
Citations: 80K

Most-cited papers

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.
M. Cavo, E. Terpos, C. Nanni, P. Moreau +24 more
2017The Lancet Oncology478 citations
Semantic Scholar
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
L. Rasche, S. Chavan, O. Stephens, P. Patel +19 more
2017Nature Communications388 citations Open access
Semantic Scholar
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.
L. Rasche, E. Angtuaco, J. McDonald, Amy F. Buros +18 more
2017Blood241 citations Open access
Semantic Scholar
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
B. Durie, A. Hoering, R. Sexton, M. Abidi +9 more
2020Blood Cancer Journal206 citations Open access
Semantic Scholar
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
N. Weinhold, C. Ashby, L. Rasche, S. Chavan +21 more
2016Blood206 citations Open access
Semantic Scholar
Combination of Flow Cytometry and Functional Imaging for Monitoring of Residual Disease in Myeloma
L. Rasche, Daisy V. Alapat, M. Kumar, G. Gershner +18 more
2018Leukemia146 citations Open access
Semantic Scholar
Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma
J. McDonald, M. M. Kessler, Michael W. Gardner, Amy F. Buros +13 more
2016Clinical Cancer Research118 citations Open access
Semantic Scholar
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project
S. Usmani, A. Hoering, M. Cavo, J. S. San Miguel +13 more
2018Blood Cancer Journal108 citations Open access
Semantic Scholar
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
E. Boyle, S. Deshpande, R. Tytarenko, C. Ashby +19 more
2021Nature Communications107 citations Open access
Semantic Scholar
The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.
L. Rasche, E. Angtuaco, Terri L Alpe, G. Gershner +18 more
2018Blood107 citations Open access
Semantic Scholar
Differentiation stage of myeloma plasma cells: biological and clinical significance
B. Paiva, N. Puig, MT Cedena, B. de Jong +27 more
2016Leukemia106 citations Open access
Semantic Scholar
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
B. Paiva, L. Corchete, M. Vidriales, N. Puig +23 more
2016Blood101 citations Open access
Semantic Scholar
Long-term outcomes after autologous stem cell transplantation for multiple myeloma.
Katherine K. Nishimura, B. Barlogie, F. van Rhee, M. Zangari +7 more
2020Blood Advances90 citations Open access
Semantic Scholar
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials
S. Ailawadhi, S. Jacobus, R. Sexton, A. Stewart +8 more
2018Blood Cancer Journal80 citations Open access
Semantic Scholar
The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma
S. Thanendrarajan, E. Tian, Ping-Ping Qu, P. Mathur +17 more
2017Haematologica76 citations Open access
Semantic Scholar
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
F. Davies, A. Rosenthal, L. Rasche, N. Petty +13 more
2018Haematologica70 citations Open access
Semantic Scholar
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials
Samuel A. Danziger, Mark McConnell, Jake Gockley, Mary H. Young +29 more
2020PLoS Medicine68 citations Open access
Semantic Scholar
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
L. Rasche, C. Schinke, Francesco Maura, M. Bauer +12 more
2022Nature Communications65 citations Open access
Semantic Scholar
Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
Ss Chavan, J. He, R. Tytarenko, S. Deshpande +24 more
2017Blood Cancer Journal63 citations Open access
Semantic Scholar
Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma
A. Laganà, Deepak Perumal, D. Melnekoff, B. Readhead +14 more
2018Leukemia58 citations
Semantic Scholar
Antigen-mediated regulation in monoclonal gammopathies and myeloma.
Shiny Nair, Joel Sng, C. S. Boddupalli, A. Seckinger +17 more
2018JCI Insight51 citations Open access
Semantic Scholar
Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling.
Vernon Wu, E. Moshier, Siyang Leng, B. Barlogie +6 more
2018Blood Advances48 citations Open access
Semantic Scholar
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease
M. Mohan, Amy F. Buros, P. Mathur, N. Gokden +16 more
2017American journal of hematology/oncology48 citations Open access
Semantic Scholar
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level
L. John, A. Poos, A. Brobeil, C. Schinke +34 more
2023Nature Communications41 citations Open access
Semantic Scholar
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
J. Sawyer, E. Tian, B. Walker, C. Wardell +10 more
2018Blood Cancer Journal41 citations Open access
Semantic Scholar
BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma
E. Boyle, C. Ashby, R. Tytarenko, S. Deshpande +24 more
2020Clinical Cancer Research37 citations Open access
Semantic Scholar
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns
C. Schinke, E. Boyle, C. Ashby, Yan Wang +17 more
2020Blood Cancer Journal36 citations Open access
Semantic Scholar
The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma
C. Schinke, Ping-Ping Qu, S. Mehdi, A. Hoering +9 more
2018Clinical Cancer Research36 citations Open access
Semantic Scholar
The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma
Caleb K Stein, C. Pawlyn, S. Chavan, L. Rasche +13 more
2017OncoTarget33 citations Open access
Semantic Scholar
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype
C. Schinke, A. Hoering, Hongwei Wang, V. Carlton +27 more
2017Haematologica30 citations Open access
Semantic Scholar
NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma
M. Hao, R. Franqui-Machin, H. Xu, J. Shaughnessy +10 more
2017Leukemia30 citations Open access
Semantic Scholar
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach
A. Laganà, I. Beno, D. Melnekoff, V. Leshchenko +15 more
2018JCO Precision Oncology27 citations Open access
Semantic Scholar
Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials.
M. Bhutani, Qing Zhang, R. Friend, P. Voorhees +8 more
2017The Lancet Haematology24 citations
Semantic Scholar
Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes
S. Mehdi, Sarah K. Johnson, J. Epstein, M. Zangari +9 more
2018British Journal of Haematology22 citations Open access
Semantic Scholar
Development and validation of an individualized and weighted myeloma prognostic score system (MPSS) in patients with newly diagnosed multiple myeloma
X. Mao, Wen-Qiang Yan, David E. Mery, Jia-Hui Liu +15 more
2024American journal of hematology/oncology20 citations Open access
Semantic Scholar
CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
Dong-Zheng Gai, Jin-Ran Chen, J. P. Stewart, I. Nookaew +17 more
2022Journal of Clinical Investigation20 citations Open access
Semantic Scholar
The Effect of Novel Therapies in High-Molecular-Risk Multiple Myeloma
Guido Lancman, D. Tremblay, Kevin Barley, B. Barlogie +6 more
2017Clinical advances in hematology & oncology : H&O19 citations
Semantic Scholar
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?
L. Rasche, M. Kumar, G. Gershner, Rohan S. Samant +16 more
2019Theranostics17 citations Open access
Semantic Scholar
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias.
A. Sridharan, C. Schinke, G. Georgiev, Maria Celoir da Silva Ferreira +26 more
2019Blood Advances15 citations Open access
Semantic Scholar
Drug response prediction in high-risk multiple myeloma.
A. Vangsted, S. Helm-Petersen, J. Cowland, P. B. Jensen +3 more
2018Gene13 citations
Semantic Scholar
A gene signature can predict risk of MGUS progressing to multiple myeloma
Fumou Sun, Yan Cheng, Jun Ying, David E. Mery +17 more
2023Journal of Hematology & Oncology11 citations Open access
Semantic Scholar
Daratumumab-induced transient myopic shift
Maria A. Mavrommatis, Hoon C. Jung, A. Chari, B. Barlogie +1 more
2018American Journal of Ophthalmology Case Reports10 citations Open access
Semantic Scholar
The Clinical Impact of Macrofocal Disease in Multiple Myeloma Differs Between Presentation and Relapse
L. Rasche, Amy F. Buros, N. Weinhold, Caleb K Stein +13 more
201610 citations
Semantic Scholar
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Kristin T Larsen, H. Spencer, M. Mohan, Clyde Bailey +21 more
2022Journal of Clinical Medicine9 citations Open access
Semantic Scholar
High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
E. Boyle, A. Rosenthal, Yan Wang, P. Farmer +14 more
2021British Journal of Haematology9 citations Open access
Semantic Scholar
E2F1 Is a Biomarker of Selinexor Resistance in Relapsed/Refractory Multiple Myeloma Patients
A. Laganà, Seongjee Park, D. Edwards, V. Leshchenko +13 more
2018Blood9 citations Open access
Semantic Scholar
Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
E. Boyle, A. Rosenthal, H. Ghamlouch, Yan Wang +17 more
2021Leukemia8 citations Open access
Semantic Scholar
PHF19 inhibition as a therapeutic target in Multiple Myeloma
C. Schinke, Jordan T. Bird, Ping-Ping Qu, S. Yaccoby +16 more
2021Current Research in Translational Medicine8 citations Open access
Semantic Scholar
Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström’s Macroglobulinemia
M. Hao, B. Barlogie, G. Tricot, Lan-Ting Liu +3 more
2018Clinical Cancer Research8 citations Open access
Semantic Scholar
Race-dependent differences in risk, genomics and Epstein-Barr virus exposure in monoclonal gammopathies: Results of SWOG S0120
M. Dhodapkar, R. Sexton, A. Hoering, F. van Rhee +2 more
2020Clinical Cancer Research6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Zangari×29
Invite
M. Zangari — researcher profile on SciRah
C. Schinke×29
Invite
C. Schinke — researcher profile on SciRah
G. Morgan×27
Invite
G. Morgan — researcher profile on SciRah
F. van Rhee×26
Invite
F. van Rhee — researcher profile on SciRah

S. Thanendrarajan

×26

Invite

S. Thanendrarajan — researcher profile on SciRah

Invite

F. Davies — researcher profile on SciRah

Invite

B. Walker — researcher profile on SciRah

Invite

A. Hoering — researcher profile on SciRah

Invite

J. Epstein — researcher profile on SciRah

N. Weinhold×14

Invite

N. Weinhold — researcher profile on SciRah

Invite

C. Ashby — researcher profile on SciRah

Invite

L. Rasche — researcher profile on SciRah